[HTML][HTML] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's …
L Nogova, T Reineke, HT Eich, A Josting… - Annals of …, 2005 - Elsevier
Background: Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkins lymphoma: a …
L Nogova, T Reineke, HT Eich, A Josting… - Annals of …, 2005 - elibrary.ru
Background: Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkins lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkins lymphoma (LPHL) remains unclear. We thus …
[PDF][PDF] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma …
L Nogová, T Reineke, HT Eich, A Josting… - 2005 - academia.edu
Background: Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
[引用][C] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma …
L NOGOVA, T REINEKE, RP MÜLLER… - Annals of …, 2005 - pascal-francis.inist.fr
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for
patients with stage IA lymphocyte-predominant Hodgkin's lymphoma : a retrospective …
patients with stage IA lymphocyte-predominant Hodgkin's lymphoma : a retrospective …
[引用][C] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma …
L Nogová, T Reineke, HT Eich, A Josting… - Annals of …, 2005 - cir.nii.ac.jp
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for
patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis …
patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis …
[HTML][HTML] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's …
L Nogová, T Reineke, HT Eich, A Josting… - Annals of …, 2005 - annalsofoncology.org
Background: Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a …
L Nogová, T Reineke, HT Eich, A Josting… - Annals of Oncology …, 2005 - europepmc.org
Background Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
[PDF][PDF] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma …
L Nogová, T Reineke, HT Eich, A Josting… - Annals of …, 2005 - Citeseer
Background: Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a …
L Nogová, T Reineke, HT Eich… - Annals of oncology …, 2005 - pubmed.ncbi.nlm.nih.gov
Background Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
[PDF][PDF] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma …
L Nogová, T Reineke, HT Eich, A Josting… - 2005 - Citeseer
Background: Since there are no randomized studies, the treatment of choice for patients with
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …
early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL) remains unclear. We thus …